查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1485121

激酶篩選和分析服務市場 - 全球產業規模、佔有率、趨勢、機會和預測，按類型、應用、地區和競爭細分，2019-2029F

Kinase Screening and Profiling Services Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type, By Application, By Region and Competition, 2019-2029F
出版日期: | 出版商: TechSci Research | 英文 185 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

2023 年，全球激酶篩選和分析服務市場價值為 3.5012 億美元，預計在預測期內將穩定成長，到 2029 年複合年成長率為 5.15%。 ，受到其在藥物發現過程和精準醫學發展中的關鍵作用的推動。激酶是一種在細胞訊號傳導和調節中發揮重要作用的酶，使其成為治療干預的有吸引力的目標。該市場描述深入探討了推動這一充滿活力的行業成長的關鍵因素。激酶篩選和分析服務市場蓬勃發展的主要驅動力之一是對新候選藥物的不懈追求。隨著製藥和生物技術公司尋求針對多種疾病的新療法，他們擴大轉向激酶分析服務來識別潛在的藥物標靶並評估候選化合物的功效和安全性。

市場概況
預測期 2025-2029
2023 年市場規模 35012萬美元
2029 年市場規模 47135萬美元
2024-2029 年複合年成長率 5.15%
成長最快的細分市場 放射性同位素法
最大的市場 北美洲

激酶作為藥物標靶的多功能性跨越了各個治療領域，包括癌症、發炎、神經退化性疾病等，進一步刺激了對篩選和分析服務的需求。對精準醫療的需求不斷成長進一步加速了市場的成長。針對個人基因組成的個人化治療變得越來越普遍。激酶分析服務對於識別激酶活性的特定基因突變和畸變至關重要，從而為標靶治療的開發提供資訊。這種方法可以實現更有效、毒性更低的治療，符合個人化醫療保健的更廣泛趨勢。標靶治療的興起是一個重要的促進因素。激酶抑制劑是標靶癌症治療的基石，激酶篩選和分析服務在確定這些療法最合適的候選藥物方面發揮關鍵作用。隨著對癌症和其他疾病遺傳基礎的了解加深，對激酶相關服務的需求預計將會成長。

高通量篩選技術的進步也有助於市場的擴張。這些技術能夠針對多個激酶標靶快速有效地測試大型化合物庫，從而簡化藥物發現過程並降低成本。不斷擴大的生物製藥和生物技術產業正在推動對激酶篩選和分析服務的需求。這些產業的特點是越來越注重開發創新和標靶療法，激酶分析是其研發工作不可或缺的一部分。慢性病，特別是癌症和自體免疫疾病的盛行率不斷上升，凸顯了對有效的激酶標靶療法的需求。激酶篩選和分析服務在識別潛在候選藥物以應對這些健康挑戰方面發揮著至關重要的作用。

主要市場促進因素

更加關注標靶治療

高通量篩選技術的進步

擴大生物製藥和生技產業

主要市場挑戰

服務提供者之間的競爭加劇

確保激酶活性測量準確且可重複

主要市場趨勢

個人化醫療需求不斷成長

在激酶分析中擴大採用人工智慧和機器學習

細分市場洞察

類型洞察

應用洞察

區域洞察

目錄

第 1 章：服務概述

  • 市場定義
  • 市場範圍
    • 涵蓋的市場
    • 研究年份
    • 主要市場區隔

第 2 章：研究方法

第 3 章：執行摘要

第 4 章：客戶之聲

第 5 章：全球激酶篩選與分析服務市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 依類型（放射性同位素法、均相非放射性同位素法）
    • 按申請（企業、研究院所）
    • 按地區
    • 按公司分類 (2023)
  • 市場地圖

第 6 章：北美激酶篩選與分析服務市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 按類型
    • 按申請
    • 按國家/地區
  • 北美：國家分析
    • 美國
    • 加拿大
    • 墨西哥

第 7 章：歐洲激酶篩選與分析服務市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 按類型
    • 按申請
    • 按國家/地區
  • 歐洲：國家分析
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙

第 8 章：亞太地區激酶篩選與分析服務市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 按類型
    • 按申請
    • 按國家/地區
  • 亞太地區：國家分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第 9 章：南美洲激酶篩選與分析服務市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 按類型
    • 按申請
    • 按國家/地區
  • 南美洲：國家分析
    • 巴西
    • 阿根廷
    • 哥倫比亞

第 10 章：中東和非洲激酶篩選和分析服務市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 按類型
    • 按申請
    • 按國家/地區
  • MEA：國家分析
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國

第 11 章：市場動態

  • 促進要素
  • 挑戰

第 12 章：市場趨勢與發展

  • 最近的發展
  • 產品發布
  • 併購

第 13 章：全球激酶篩選與分析服務市場：SWOT 分析

第14章：競爭格局

  • MedChemExpress LLC
  • Eurofins Scientific SE
  • Thermo Fisher Scientific, Inc.
  • Reaction Biology Corp.
  • BPS Bioscience, Inc.
  • Creative Biogene Inc.
  • Luceome Biotechnologies LLC
  • Kinexus Bioinformatics Corp.
  • LC Sciences LLC
  • HD Biosciences Co., Ltd.

第 15 章：策略建議

第16章調查會社について,免責事項

簡介目錄
Product Code: 22237

Global Kinase Screening and Profiling Services Market was valued at USD 350.12 Million in 2023 and is anticipated to project steady growth in the forecast period with a CAGR of 5.15% through 2029. The Global Kinase Screening and Profiling Services Market is witnessing robust growth and significant demand, driven by its critical role in the drug discovery process and the development of precision medicine. Kinases are enzymes that play a vital role in cell signaling and regulation, making them attractive targets for therapeutic interventions. This market description delves into the key factors propelling the growth of this dynamic sector. One of the primary drivers behind the flourishing Kinase Screening and Profiling Services Market is the relentless pursuit of new drug candidates. As pharmaceutical and biotechnology companies seek novel therapies for a wide range of diseases, they increasingly turn to kinase profiling services to identify potential drug targets and assess the efficacy and safety of candidate compounds.

Market Overview
Forecast Period2025-2029
Market Size 2023USD 350.12 Million
Market Size 2029USD 471.35 Million
CAGR 2024-20295.15%
Fastest Growing SegmentRadioisotope Method
Largest MarketNorth America

The versatility of kinases as drug targets spans various therapeutic areas, including cancer, inflammation, neurodegenerative disorders, and more, further fueling the demand for screening and profiling services. The market's growth is further accelerated by the growing demand for precision medicine. Personalized treatments tailored to an individual's genetic makeup are becoming increasingly common. Kinase profiling services are essential for identifying specific genetic mutations and aberrations in kinase activity that can inform the development of targeted therapies. This approach allows for more effective and less toxic treatments, aligning with the broader trend towards personalized healthcare. The rise of targeted therapies is a significant driver. Kinase inhibitors are a cornerstone of targeted cancer therapies, and kinase screening and profiling services play a pivotal role in identifying the most suitable candidates for these therapies. As the understanding of the genetic basis of cancer and other diseases deepens, the demand for kinase-related services is expected to grow.

Advancements in high-throughput screening technologies are also contributing to the market's expansion. These technologies enable rapid and efficient testing of large compound libraries against multiple kinase targets, streamlining the drug discovery process and reducing costs. The expanding biopharmaceutical and biotechnology industries are driving the need for kinase screening and profiling services. These sectors are characterized by an increasing focus on developing innovative and targeted therapies, and kinase profiling is integral to their research and development efforts. The rising prevalence of chronic diseases, particularly cancer and autoimmune disorders, underscores the need for effective kinase-targeted therapies. Kinase screening and profiling services play a crucial role in identifying potential drug candidates to address these health challenges.

Key Market Drivers

Increased focus on targeted therapies

The Global Kinase Screening and Profiling Services Market is experiencing substantial growth due to the increased focus on targeted therapies. Targeted therapies represent a paradigm shift in the field of medicine, aiming to treat diseases by precisely targeting the underlying molecular and genetic abnormalities. Kinases, a class of enzymes that play crucial roles in cellular signalling pathways, have emerged as prominent targets for these therapies. This market description explores how the emphasis on targeted therapies is driving the expansion of the Kinase Screening and Profiling Services Market. One of the primary drivers behind the market's growth is the rising recognition of kinases as essential therapeutic targets. Dysregulation or mutation of kinases is implicated in various diseases, including cancer, inflammatory disorders, and neurodegenerative conditions. The specificity of kinase inhibitors allows for more precise and effective treatments, reducing off-target effects and minimizing collateral damage to healthy tissues.

To develop targeted therapies, pharmaceutical and biotechnology companies require comprehensive kinase screening and profiling services. These services enable the identification of specific kinase targets and help assess the efficacy of candidate compounds in modulating kinase activity. With a growing pipeline of targeted therapy candidates, the demand for kinase profiling services is surging. Cancer treatment exemplifies the impact of targeted therapies on the Kinase Screening and Profiling Services Market. Many approved cancer drugs are kinase inhibitors designed to block the activity of specific kinases responsible for promoting tumor growth. Kinase profiling services play a pivotal role in identifying the most promising drug candidates and optimizing treatment strategies for individual patients based on their genetic profiles. The move towards personalized cancer care further accelerates the demand for these services.

As the understanding of the genetic basis of diseases deepens through initiatives like genomics and precision medicine, the importance of kinase profiling becomes even more pronounced. The ability to identify specific genetic mutations and aberrant kinase activities informs the development of tailored therapies for patients with specific genetic alterations. In conclusion, the increased focus on targeted therapies, especially in the context of kinase-targeted treatments, is a driving force behind the growth of the Global Kinase Screening and Profiling Services Market. With a relentless pursuit of precision medicine and the development of therapies tailored to individual patients, this market is set to play a pivotal role in advancing healthcare by facilitating the discovery and optimization of targeted therapies across various disease areas.

Advancements in high-throughput screening technologies

Advancements in high-throughput screening technologies are propelling the Global Kinase Screening and Profiling Services Market to new heights. These technological innovations are revolutionizing the drug discovery process, making it faster, more efficient, and cost-effective. In the context of kinase screening and profiling services, high-throughput technologies are driving several key advancements that are shaping the market's growth. One of the primary drivers is the acceleration of drug discovery and development. High-throughput screening (HTS) enables the rapid testing of thousands or even millions of compounds against multiple kinase targets simultaneously. This greatly expedites the identification of potential drug candidates with kinase-modulating activity. As the demand for novel therapies, especially targeted treatments, continues to surge, HTS technologies are essential for quickly identifying promising leads.

HTS technologies enhance the efficiency of kinase profiling services. These techniques allow for the comprehensive analysis of kinase activity against a wide range of compounds, enabling researchers to assess compound selectivity and specificity. This information is crucial for optimizing drug candidates and minimizing off-target effects, a critical consideration in targeted therapies. Moreover, the cost-effectiveness of high-throughput screening is driving its adoption across the pharmaceutical and biotechnology industries. By automating and miniaturizing the screening process, HTS technologies reduce the time and resources required for compound testing. This cost efficiency is particularly valuable as companies strive to maximize their research and development budgets.

The accuracy and reproducibility of HTS technologies enhance data quality. This is of paramount importance in kinase screening and profiling services, where precise measurements of kinase activity are vital for identifying potential drug candidates. The reliability of HTS data ensures that researchers can make informed decisions about which compounds to advance in drug development pipelines. Another critical aspect is the scalability of high-throughput screening technologies. They can be applied to a wide range of compound libraries and kinase targets, making them adaptable to the evolving needs of the drug discovery process. This flexibility positions HTS as an indispensable tool in the pursuit of novel kinase-targeted therapies.

Expanding biopharmaceutical and biotechnology industries

The Global Kinase Screening and Profiling Services Market is experiencing significant growth, primarily attributed to the expanding biopharmaceutical and biotechnology industries. These sectors are at the forefront of scientific research, drug development, and therapeutic innovations, and kinases have emerged as crucial targets for a wide range of applications. This market description explores how the remarkable expansion of the biopharmaceutical and biotechnology industries is driving the Kinase Screening and Profiling Services Market. One of the primary drivers is the growing demand for kinase-targeted therapies. The biopharmaceutical and biotechnology sectors are actively involved in the development of precision medicines, including targeted therapies for cancer, inflammatory diseases, and autoimmune disorders. Kinases are central to these therapeutic approaches, as they regulate critical cellular processes involved in disease progression. As the pipelines for targeted therapies expand, the need for kinase screening and profiling services to identify potential drug candidates' surges.

The biopharmaceutical and biotechnology industries are increasingly focusing on biologics, including monoclonal antibodies and other large molecules. Kinases play a role in the development of these biologics, influencing their efficacy and safety. The demand for kinase screening and profiling services extends to optimizing biologics targeting kinase-related pathways. The global biopharmaceutical market is also experiencing rapid growth due to the increased prevalence of chronic diseases, an aging population, and the demand for innovative healthcare solutions. Many chronic diseases, such as cancer and neurodegenerative disorders, involve dysregulated kinase signaling pathways. Kinase screening and profiling services are vital in identifying novel drug candidates and understanding disease mechanisms. The biopharmaceutical and biotechnology sectors are characterized by a strong emphasis on research and development. With substantial investments in drug discovery, these industries continually seek to identify new therapeutic targets and develop innovative treatments. Kinase profiling services offer invaluable insights into the potential of kinase-targeted therapies, enabling more informed decisions in the drug development process.

Key Market Challenges

Increasing competition among service providers

Increasing competition among service providers poses a significant challenge for the Global Kinase Screening and Profiling Services Market. While competition is a driving force for innovation and potentially lowers costs for consumers, it introduces complexities and pressures within the industry that require careful consideration.

One of the primary challenges is maintaining service quality and differentiation. As more service providers enter the market, customers are presented with a broader array of choices. This intensifies the need for service providers to continually invest in cutting-edge technologies, experienced personnel, and rigorous quality assurance processes to stand out and meet evolving customer demands. The competitive landscape often leads to pricing pressures. Service providers may engage in price wars to attract and retain clients, potentially compromising their profitability and sustainability. Balancing cost-effectiveness with quality becomes a delicate challenge in such a competitive environment. Competition can fragment the market, making it harder for customers to navigate the plethora of service options. This fragmentation can lead to confusion and a lack of standardized practices, potentially hindering the industry's growth. As competition increases, service providers may face challenges in maintaining profitability. Lower prices and the need to continually invest in research and development can squeeze profit margins, particularly for smaller companies.

Ensuring accurate and reproducible kinase activity measurements

Ensuring accurate and reproducible kinase activity measurements represents a significant challenge for the Global Kinase Screening and Profiling Services Market. The reliability and precision of kinase data are paramount for drug discovery and development, making this challenge particularly critical. One of the key issues is the complexity of kinase assays. Kinase activity is influenced by numerous factors, including buffer conditions, substrate concentrations, and assay kinetics. Variability in any of these parameters can lead to inconsistent results. Maintaining consistency across assays, especially when conducted by different laboratories or even within the same laboratory over time, is a formidable challenge. Kinase assays often involve intricate cellular or biochemical processes. Variability in the source of kinases, such as recombinant kinases, primary cells, or tissues, can introduce inconsistencies in measurements. Ensuring that the source material is standardized and reproducible across experiments is a significant challenge. Another challenge is the need for robust assay validation. Validating kinase assays to demonstrate their accuracy, precision, and reliability is a time-consuming and resource-intensive process. Ensuring that assay validation is performed rigorously and consistently is essential for maintaining data integrity.

The evolving nature of kinases and their involvement in various diseases necessitates continuous adaptation of assays. Staying up to date with the latest scientific discoveries and incorporating new knowledge into assay protocols is a challenge for service providers. Standardization across different laboratories and organizations is also a challenge. To facilitate data sharing and collaboration, it is essential to establish common assay standards and protocols. Achieving consensus in the industry on these standards can be challenging. In summary, ensuring accurate and reproducible kinase activity measurements is a complex challenge for the Kinase Screening and Profiling Services Market. Overcoming this challenge requires meticulous attention to assay design, validation, source material consistency, and ongoing adaptation to the evolving understanding of kinase biology, all of which are vital for the market's success in supporting drug discovery and development efforts.

Key Market Trends

Growing demand for personalized medicine

The growing demand for personalized medicine is a significant trend shaping the Global Kinase Screening and Profiling Services Market. Personalized medicine, also known as precision medicine, is an approach that tailors medical treatment to individual patients based on their genetic makeup, allowing for more targeted and effective therapies. Kinase profiling services play a crucial role in this paradigm shift towards personalized medicine in several ways: Development: Personalized medicine relies on identifying specific genetic mutations or aberrant kinase activities that drive a patient's disease. Kinase profiling services help identify the most suitable kinase targets and potential drug candidates for these unique genetic profiles. This approach enables the development of highly targeted therapies, minimizing side effects and increasing treatment efficacy. Kinase profiling assists in the discovery of biomarkers associated with particular diseases or treatment responses. These biomarkers serve as indicators of disease progression or therapeutic efficacy, aiding in patient stratification and treatment decision-making. Kinase profiling can be used to monitor a patient's response to therapy over time. Changes in kinase activity profiles can provide valuable insights into treatment effectiveness and help clinicians adjust therapeutic strategies as needed.

The trend toward personalized medicine has led to an increase in clinical trials that incorporate patient-specific genetic information. Kinase profiling services are essential for identifying eligible patients, optimizing treatment regimens, and assessing trial outcomes. As the demand for personalized medicine continues to grow, the Kinase Screening and Profiling Services Market is expected to expand to meet the requirements of pharmaceutical companies, research institutions, and healthcare providers seeking tailored solutions for drug development and patient care. This trend underscores the critical role that kinase profiling plays in advancing precision medicine and improving patient outcomes.

Increasing adoption of AI and machine learning in kinase profiling

The increasing adoption of artificial intelligence (AI) and machine learning (ML) in kinase profiling is a transformative trend in the Global Kinase Screening and Profiling Services Market. AI and ML technologies are revolutionizing the way kinase data is analyzed, interpreted, and applied, driving innovation and efficiency in drug discovery and development. One key aspect of this trend is the automation of data analysis. Kinase profiling generates vast datasets, and AI/ML algorithms can swiftly and accurately process this information, identifying meaningful patterns, correlations, and potential kinase inhibitors. This significantly accelerates the drug discovery process by reducing the time and resources required for data interpretation. AI and ML enhance predictive modeling. These technologies can predict kinase-drug interactions, compound binding affinities, and potential therapeutic outcomes with a high degree of accuracy. Such predictive capabilities empower researchers to make informed decisions about which compounds to advance in their pipelines, ultimately improving the success rate of drug development.

AI and ML are being used to optimize experimental designs and assay protocols. Through iterative learning, these technologies can suggest refinements in assay conditions, such as substrate concentrations or reaction times, to maximize data quality and reproducibility. AI-driven precision medicine approaches are becoming more prevalent. By integrating patient-specific genetic data, clinical information, and kinase profiling results, AI/ML can identify the most suitable targeted therapies for individual patients, aligning with the broader trend towards personalized medicine. In summary, the increasing adoption of AI and machine learning in kinase profiling is a transformative trend in the Kinase Screening and Profiling Services Market. These technologies offer enhanced data analysis, predictive modeling, assay optimization, and personalized medicine applications, revolutionizing the way kinase-related research and drug development are conducted. As AI and ML continue to advance, their integration into kinase profiling services is expected to drive efficiency, precision, and innovation in the field.

Segmental Insights

Type Insights

Based on Type, the Radioisotope Method emerged with the rapid growth in the Global Kinase Screening and Profiling Services Market primarily due to its high sensitivity, accuracy, and versatility in studying kinase activity. This method involves the use of radioactive isotopes to label substrates or ATP, allowing for precise measurement of kinase activity, making it a preferred choice for many researchers and service providers. Several factors contribute to the dominance of the Radioisotope Method: Radioisotopes provide exceptional sensitivity, allowing for the detection of low levels of kinase activity. This level of sensitivity is crucial for accurately measuring kinase activity in complex biological samples. Radioisotope-based assays can be adapted to assess a broad range of kinases and substrates, making them versatile for various research and drug development applications. The Radioisotope Method has a long history in kinase research and is considered a gold standard due to its reliability and established protocols. This legacy has fostered trust among researchers and service providers. Radioisotope assays provide quantitative data, enabling precise measurements of kinase activity. This quantitative output is valuable for dose-response studies and drug screening efforts. Despite concerns about safety and disposal, the Radioisotope Method can still be adapted for high-throughput screening (HTS). Researchers can conduct large-scale kinase profiling with high accuracy and efficiency.

Application Insights

Based on Application, Research institutes emerged as the dominant segment in the Global Kinase Screening and Profiling Services Market during forecast period. This is due to their critical contributions to scientific advancements and drug discovery. These institutions are hubs of innovation, where cutting-edge research is conducted to better understand disease mechanisms and identify potential therapeutic targets, often involving kinases. With their focus on foundational research, research institutes drive the demand for kinase profiling services to support their studies. Their collaborative and multidisciplinary environments make them ideal clients for service providers, and they often serve as key partners in advancing kinase-related research, making them a pivotal force in the market's growth and development.

Regional Insights

Based on region, North America held dominance in the Global Kinase Screening and Profiling Services Market in 2023. This is due to its thriving pharmaceutical and biotechnology industry, well-established research infrastructure, and a robust ecosystem of service providers. The United States, in particular, is home to numerous pharmaceutical companies, research institutions, and biotech startups engaged in kinase-related research and drug development. The region benefits from significant investments in healthcare and life sciences, favorable regulatory frameworks, and a skilled workforce. This combination of factors positions North America as a powerhouse in kinase profiling services, attracting both domestic and international clients and contributing to its leadership in the market.

Key Market Players

MedChemExpress LLC

Eurofins Scientific SE

Thermo Fisher Scientific, Inc.

Reaction Biology Corp.

BPS Bioscience, Inc.

Creative Biogene Inc.

Luceome Biotechnologies L.L.C.

Kinexus Bioinformatics Corp.

LC Sciences LLC

HD Biosciences Co., Ltd.

Report Scope:

In this report, the Global Kinase Screening and Profiling Services Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Kinase Screening and Profiling Services Market, By Type:

    Radioisotope Method Homogeneous Non-radioisotope Method

Kinase Screening and Profiling Services Market, By Application:

    Enterprise Research Institute

Kinase Screening and Profiling Services Market, By Region:

    North America

United States

Canada

Mexico

    Europe

France

United Kingdom

Italy

Germany

Spain

    Asia Pacific

China

India

Japan

Australia

South Korea

    South America

Brazil

Argentina

Colombia

    Middle East & Africa

South Africa

Saudi Arabia

UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Kinase Screening and Profiling Services Market.

Available Customizations:

Global Kinase Screening and Profiling Services Market report with the given market data, Tech Sci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Service Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Kinase Screening and Profiling Services Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Type (Radioisotope Method, Homogeneous Non-radioisotope Method)
    • 5.2.2. By Application (Enterprise, Research Institute)
    • 5.2.3. By Region
    • 5.2.4. By Company (2023)
  • 5.3. Market Map

6. North America Kinase Screening and Profiling Services Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Type
    • 6.2.2. By Application
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Kinase Screening and Profiling Services Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Type
        • 6.3.1.2.2. By Application
    • 6.3.2. Canada Kinase Screening and Profiling Services Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Type
        • 6.3.2.2.2. By Application
    • 6.3.3. Mexico Kinase Screening and Profiling Services Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Type
        • 6.3.3.2.2. By Application

7. Europe Kinase Screening and Profiling Services Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Type
    • 7.2.2. By Application
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Kinase Screening and Profiling Services Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Type
        • 7.3.1.2.2. By Application
    • 7.3.2. United Kingdom Kinase Screening and Profiling Services Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Type
        • 7.3.2.2.2. By Application
    • 7.3.3. Italy Kinase Screening and Profiling Services Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Type
        • 7.3.3.2.2. By Application
    • 7.3.4. France Kinase Screening and Profiling Services Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Type
        • 7.3.4.2.2. By Application
    • 7.3.5. Spain Kinase Screening and Profiling Services Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Type
        • 7.3.5.2.2. By Application

8. Asia Pacific Kinase Screening and Profiling Services Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Type
    • 8.2.2. By Application
    • 8.2.3. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Kinase Screening and Profiling Services Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Type
        • 8.3.1.2.2. By Application
    • 8.3.2. India Kinase Screening and Profiling Services Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Type
        • 8.3.2.2.2. By Application
    • 8.3.3. Japan Kinase Screening and Profiling Services Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Type
        • 8.3.3.2.2. By Application
    • 8.3.4. South Korea Kinase Screening and Profiling Services Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Type
        • 8.3.4.2.2. By Application
    • 8.3.5. Australia Kinase Screening and Profiling Services Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Type
        • 8.3.5.2.2. By Application

9. South America Kinase Screening and Profiling Services Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Type
    • 9.2.2. By Application
    • 9.2.3. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Kinase Screening and Profiling Services Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Type
        • 9.3.1.2.2. By Application
    • 9.3.2. Argentina Kinase Screening and Profiling Services Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Type
        • 9.3.2.2.2. By Application
    • 9.3.3. Colombia Kinase Screening and Profiling Services Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Type
        • 9.3.3.2.2. By Application

10. Middle East and Africa Kinase Screening and Profiling Services Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Type
    • 10.2.2. By Application
    • 10.2.3. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Kinase Screening and Profiling Services Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Type
        • 10.3.1.2.2. By Application
    • 10.3.2. Saudi Arabia Kinase Screening and Profiling Services Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Type
        • 10.3.2.2.2. By Application
    • 10.3.3. UAE Kinase Screening and Profiling Services Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Type
        • 10.3.3.2.2. By Application

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Recent Developments
  • 12.2. Product Launches
  • 12.3. Mergers & Acquisition

13. Global Kinase Screening and Profiling Services Market : SWOT Analysis

14. Competitive Landscape

  • 14.1. MedChemExpress LLC
    • 14.1.1. Business Overview
    • 14.1.2. Products & Services
    • 14.1.3. Recent Developments
    • 14.1.4. Key Personnel
    • 14.1.5. SWOT Analysis
  • 14.2. Eurofins Scientific SE
  • 14.3. Thermo Fisher Scientific, Inc.
  • 14.4. Reaction Biology Corp.
  • 14.5. BPS Bioscience, Inc.
  • 14.6. Creative Biogene Inc.
  • 14.7. Luceome Biotechnologies L.L.C.
  • 14.8. Kinexus Bioinformatics Corp.
  • 14.9. LC Sciences LLC
  • 14.10.HD Biosciences Co., Ltd.

15. Strategic Recommendations

16. About Us & Disclaimer